Franck A.
- Country
- France
- Department
- Hepatogastroenterology
Research Overview
- Evaluation of Oxaliplatin-Based Chemotherapy for Lean Body Mass Normalization in Patients with Colon Cancer
- Phase II Randomized Study of 5-Fluorouracil/Leucovorin, Irinotecan, Gemcitabine, and Paclitaxel in Metastatic Pancreatic Cancer
- Postoperative Hepatic Arterial Oxaliplatin Infusion Combined with Systemic Chemotherapy for High‑Risk Resected Colorectal Liver Metastases: A Randomized Phase II Trial
Data & Insights
Has run more than one trial at 200 of 350 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in the treatment of various gastrointestinal cancers, with particular emphasis on colorectal adenocarcinoma and colon carcinoma. Their research includes innovative approaches to personalized treatment using circulating tumor DNA for treatment decision-making.
- Colorectal Cancer Management
- Molecular-guided Treatment Strategies
- Adjuvant Therapy Optimization
Digestive System Oncology
Focus areas include pancreatic adenocarcinoma, hepatocellular carcinoma, and ampullary adenocarcinoma. The investigator works with novel therapeutic approaches including targeted therapies and immunotherapy combinations.
- Pancreatic Cancer Treatment
- Liver Cancer Therapeutics
- Small Bowel Cancer Management
Precision Medicine
Expertise in developing personalized treatment approaches, including research on enzyme deficiency-based dosing and targeted therapeutic strategies. Special focus on molecular-guided therapy selection and treatment optimization for elderly patients.
- Biomarker-driven Treatment
- Chemotherapy Optimization
- Targeted Therapy Development
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.